|Lancet Commission: Stem cells and regenerative medicine|
G Cossu, M Birchall, T Brown, P De Coppi, E Culme-Seymour, S Gibbon, ...
The Lancet 391 (10123), 883-910, 2018
|A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease.|
J Dretzke, R Edlin, J Round, M Connock, C Hulme, J Czeczot, A Fry-Smith, ...
Health Technology Assessment (Winchester, England) 15 (6), 1, 2011
|Behavioural and psychiatric symptoms in people with dementia admitted to the acute hospital: prospective cohort study|
EL Sampson, N White, B Leurent, S Scott, K Lord, J Round, L Jones
The British Journal of Psychiatry 205 (3), 189-196, 2014
|An educational review of the statistical issues in analysing utility data for cost-utility analysis|
RM Hunter, G Baio, T Butt, S Morris, J Round, N Freemantle
Pharmacoeconomics 33 (4), 355-366, 2015
|An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary …|
KME Turner, J Round, P Horner, J Macleod, S Goldenberg, A Deol, ...
Sexually transmitted infections 90 (2), 104-111, 2014
|Rehabilitation in advanced, progressive, recurrent cancer: a randomized controlled trial|
L Jones, G FitzGerald, B Leurent, J Round, J Eades, S Davis, F Gishen, ...
Journal of pain and symptom management 46 (3), 315-325. e3, 2013
|Updated cost-effectiveness analysis of trastuzumab for early breast cancer|
PS Hall, C Hulme, C McCabe, Y Oluboyede, J Round, DA Cameron
Pharmacoeconomics 29 (5), 415-432, 2011
|Is a QALY still a QALY at the end of life?|
Journal of Health Economics 31 (3), 521 - 527, 2012
|Estimating the cost of caring for people with cancer at the end of life: a modelling study|
J Round, L Jones, S Morris
Palliative medicine 29 (10), 899-907, 2015
|Screening for gestational diabetes mellitus: cost–utility of different screening strategies based on a woman’s individual risk of disease|
JA Round, P Jacklin, RB Fraser, RG Hughes, MA Mugglestone, RIG Holt
Diabetologia 54 (2), 256-263, 2011
|Urinary tract infections in children and the risk of ESRF|
J Round, AC Fitzgerald, C Hulme, M Lakhanpaul, K Tullus
Acta Paediatrica 101 (3), 278-282, 2012
|A safer place for patients: learning to improve patient safety|
A Terry, C Mottram, J Round, E Firman, J Step, J Bourne
The Stationary Office, 2005
|Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR)|
DS Kessler, SJ MacNeill, D Tallon, G Lewis, TJ Peters, W Hollingworth, ...
bmj 363, 2018
|Sorafenib for the treatment of advanced hepatocellular carcinoma|
M Connock, J Round, S Bayliss, S Tubeuf, W Greenheld, D Moore
Health Technol Assess 14 (Suppl 1), 17-21, 2010
|Economic considerations in the provision of treatments for rare diseases|
C McCabe, R Edlin, J Round
Rare diseases epidemiology, 211-222, 2010
|Cirrhosis with ascites in the last year of life: a nationwide analysis of factors shaping costs, health-care use, and place of death in England|
B Hudson, J Round, B Georgeson, A Pring, K Forbes, CA McCune, ...
The lancet Gastroenterology & hepatology 3 (2), 95-103, 2018
|Incorporating equity in economic evaluations: a multi-attribute equity state approach|
J Round, M Paulden
The European Journal of Health Economics 19 (4), 489-498, 2018
|Promoting independence, health and well-being for older people: a feasibility study of computer-aided health and social risk appraisal system in primary care|
K Walters, K Kharicha, C Goodman, M Handley, J Manthorpe, M Cattan, ...
BMC family practice 18 (1), 1-10, 2017
|ISSCR guidelines for stem cell research and clinical translation: the 2021 update|
R Lovell-Badge, E Anthony, RA Barker, T Bubela, AH Brivanlou, ...
Stem cell reports 16 (6), 1398-1408, 2021
|Total ankle replacement versus arthrodesis (TARVA): protocol for a multicentre randomised controlled trial|
AJ Goldberg, R Zaidi, C Thomson, CJ Doré, SS Skene, S Cro, J Round, ...
BMJ open 6 (9), e012716, 2016